Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date March 08, 2004 · Filed April 16, 2004
Section 16 reporting ended · disclosed 2004-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.20 · Expires 2014-02-22 | IndirectBy Wife | 225,000 |
Reported balance
After 2004-03-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2004-03-08 · Gift · Acquired 225,000 · Balance 225,000 F2: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, and generally exercisable in one-third increments on February 24 of each 2005, 2006 and 2007 subject to the conditions of employment separation. F3: Reporting person transferred the reported option to his wife. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.20 · Expires 2014-02-22 | Direct | 0 |
Reported balance
After 2004-03-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2004-03-08 · Gift · Disposed 225,000 · Balance 0 F2: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, and generally exercisable in one-third increments on February 24 of each 2005, 2006 and 2007 subject to the conditions of employment separation. |
| Common SharesSEC Table I · non-derivative | IndirectBy Wife | 29,187 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 29,187 F1: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common SharesSEC Table I · non-derivative | Direct | 165,410 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 165,410 |
| Deferred Stock Unit AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 62,186 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 62,186 F4: Not Applicable. F5: Granted under the Stock Incentive Plans. Of the 62,186 shares, 32,186 vest and are distributed in twenty-percent increments from 2005 to 2008 and 30,000 vest and are distributed on February 23, 2007, in accordance with the Plans and subject to the conditions of employment separation. F6: Not Applicable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.85 · Expires 2013-02-23 | IndirectBy Wife | 108,100 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 108,100 F7: Options were granted on February 24, 2003 and are exercisable in one-third increments on February 25 of each 2004, 2005 and 2006 subject to the conditions of employment separation. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.85 · Expires 2013-02-23 | IndirectBy Wife | 138,000 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 138,000 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.77 · Expires 2005-02-26 | Direct | 25,760 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 25,760 F8: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.81 · Expires 2005-12-10 | Direct | 300,000 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 300,000 F9: 180,000 options are currently exercisable. 60,000 become exercisable on 12/12/2003 and 60,000 become exercisable on 12/12/2004 subject to the conditions of employment separation. F10: The terms of the option grant provide that in the event of retirement under a retirement plan of the Issuer or a subsidiary: (i) on or after normal retirement date, 100% of the shares granted hereby shall become fully exercisable as of such retirement date; or (ii) on an early retirement date, the shares granted hereby shall become exercisable only to the extent approved by the Committee but in no event shall shares be exercisable hereunder if such early retirement is prior to December 12, 1996. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.97 · Expires 2006-02-25 | Direct | 34,700 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 34,700 F8: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.81 · Expires 2007-02-23 | Direct | 70,800 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 70,800 F8: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.13 · Expires 2008-02-22 | Direct | 70,800 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 70,800 F8: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.06 · Expires 2009-02-21 | Direct | 67,200 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 67,200 F8: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.75 · Expires 2010-02-21 | Direct | 67,200 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 67,200 F8: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.04 · Expires 2010-09-24 | Direct | 260,000 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 260,000 F11: Options were granted on September 25, 2000 and are exercisable in one-third increments on September 26 of each 2003, 2004 and 2005 subject to the conditions of employment separation. F12: The terms of the option grant provide that in the event of retirement under a retirement plan of the Issuer or a subsidiary: (i) on or after normal retirement date, the shares granted hereby shall vest in accordance with the schedule set forth in Footnote 11 above; or (ii) on an early retirement date, the shares granted hereby shall become exercisable only to the extent approved by the Committee but in no event shall shares be exercisable hereunder if such early retirement is prior to September 26, 2003. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.05 · Expires 2011-02-25 | Direct | 138,000 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 138,000 F8: These options are currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.68 · Expires 2012-02-24 | Direct | 138,000 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 138,000 F8: These options are currently exercisable. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 324,466.36 |
Reported balance
Holding disclosure · report date 2004-03-08 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 324,466.36 F13: 1 for 1 F14: Includes grants under the Long-Term Performance Share Unit Incentive Plan and the Transformational Performance Contingent Shares Program. Vested shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. F15: Includes 993.36 shares of phantom stock acquired pursuant to a dividend reinvestment feature of the Long-Term Performance Share Unit Incentive Plan and the Transformational Performance Contingent Shares Program. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, and generally exercisable in one-third increments on February 24 of each 2005, 2006 and 2007 subject to the conditions of employment separation.
F3: Reporting person transferred the reported option to his wife.
F4: Not Applicable.
F5: Granted under the Stock Incentive Plans. Of the 62,186 shares, 32,186 vest and are distributed in twenty-percent increments from 2005 to 2008 and 30,000 vest and are distributed on February 23, 2007, in accordance with the Plans and subject to the conditions of employment separation.
F6: Not Applicable.
F7: Options were granted on February 24, 2003 and are exercisable in one-third increments on February 25 of each 2004, 2005 and 2006 subject to the conditions of employment separation.
F8: These options are currently exercisable.
F9: 180,000 options are currently exercisable. 60,000 become exercisable on 12/12/2003 and 60,000 become exercisable on 12/12/2004 subject to the conditions of employment separation.
F10: The terms of the option grant provide that in the event of retirement under a retirement plan of the Issuer or a subsidiary: (i) on or after normal retirement date, 100% of the shares granted hereby shall become fully exercisable as of such retirement date; or (ii) on an early retirement date, the shares granted hereby shall become exercisable only to the extent approved by the Committee but in no event shall shares be exercisable hereunder if such early retirement is prior to December 12, 1996.
F11: Options were granted on September 25, 2000 and are exercisable in one-third increments on September 26 of each 2003, 2004 and 2005 subject to the conditions of employment separation.
F12: The terms of the option grant provide that in the event of retirement under a retirement plan of the Issuer or a subsidiary: (i) on or after normal retirement date, the shares granted hereby shall vest in accordance with the schedule set forth in Footnote 11 above; or (ii) on an early retirement date, the shares granted hereby shall become exercisable only to the extent approved by the Committee but in no event shall shares be exercisable hereunder if such early retirement is prior to September 26, 2003.
F13: 1 for 1
F14: Includes grants under the Long-Term Performance Share Unit Incentive Plan and the Transformational Performance Contingent Shares Program. Vested shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer.
F15: Includes 993.36 shares of phantom stock acquired pursuant to a dividend reinvestment feature of the Long-Term Performance Share Unit Incentive Plan and the Transformational Performance Contingent Shares Program.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2004 Filed Apr 16, 2004 18:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | GiftOption (Right to Buy) · Derivative | 225,000 | $18.20 Strike: $18.20 | $4,095,000.00 |
DisclosureSEC source: 0000310158-04-000058 · con389.xml · derivative · entry 4 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 225,000 shares Expires 2014-02-22 F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, and generally exercisable in one-third increments on February 24 of each 2005, 2006 and 2007 subject to the conditions of employment separation. Read SEC document |
| March 08, 2004 Filed Apr 16, 2004 18:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | GiftOption (Right to Buy) · Derivative | 225,000 | $18.20 Strike: $18.20 | $4,095,000.00 |
DisclosureSEC source: 0000310158-04-000058 · con389.xml · derivative · entry 3 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 225,000 Underlying: Common Shares · 225,000 shares Expires 2014-02-22 F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, and generally exercisable in one-third increments on February 24 of each 2005, 2006 and 2007 subject to the conditions of employment separation. F3 · ownership.nature: Reporting person transferred the reported option to his wife. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 21:03 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantPhantom Stock Units · Derivative | 323,473 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000044 · con357.xml · derivative · entry 4 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,473 Underlying: Common Shares · 323,473 shares Expires not disclosed F8 · derivative.exercise_price: 1 for 1 F10 · price: Not Applicable. F9 · derivative.exercise_date: Includes grants under the Long-Term Performance Share Unit Incentive Plan and the Transformational Performance Contingent Shares Program. The shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. F9 · derivative.expiration_date: Includes grants under the Long-Term Performance Share Unit Incentive Plan and the Transformational Performance Contingent Shares Program. The shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 21:03 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (Right to Buy) · Derivative | 225,000 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0000310158-04-000044 · con357.xml · derivative · entry 3 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Shares · 225,000 shares Expires 2014-02-22 F7 · price: Not Applicable. F6 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on February 24 of each 2005, 2006 and 2007. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 21:03 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 30,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000044 · con357.xml · derivative · entry 2 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,318 Underlying: Common Shares · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. All of the shares become deliverable on February 23, 2007. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 21:03 UTC | Merck & Co., Inc. SGP · Entity 2807 | OtherDeferred Stock Unit Award · Derivative | 33,540 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000044 · con357.xml · derivative · entry 1 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,318 Underlying: Common Shares · 33,540 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F2 · kind: 10,660 shares vested from the original performance award of 44,200 shares granted on 2/24/2003; unvested shares from original grant forfeited and deducted from total. Twenty percent of the award becomes deliverable annually. F4 · price: Not Applicable. F2 · derivative.exercise_date: 10,660 shares vested from the original performance award of 44,200 shares granted on 2/24/2003; unvested shares from original grant forfeited and deducted from total. Twenty percent of the award becomes deliverable annually. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 23, 2004 Filed Mar 15, 2004 16:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 2,132 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000049 · con378.xml · derivative · entry 4 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,186 Underlying: Common Shares · 2,132 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 23, 2004 Filed Mar 15, 2004 16:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 913 | $18.20 | $16,616.60 |
DisclosureSEC source: 0000310158-04-000049 · con378.xml · nonDerivative · entry 2 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,410 Read SEC document |
| February 23, 2004 Filed Mar 15, 2004 16:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 2,132 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-04-000049 · con378.xml · nonDerivative · entry 1 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 27,122 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · derivative · entry 7 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,858 Underlying: Common Shares · 27,122 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Not Applicable. F8 · price: Not Applicable. F6 · derivative.exercise_date: Not Applicable. F7 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 26,440 | $7.45 Strike: $7.45 | $196,978.00 |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · derivative · entry 6 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 26,440 shares Expires 2004-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are currently exercisable. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 11,615 | $16.63 | $193,157.45 |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · nonDerivative · entry 4 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,191 Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 18,343 | $16.05 | $294,405.15 |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · nonDerivative · entry 3 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,806 Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 26,440 | $7.45 | $196,978.00 |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · nonDerivative · entry 2 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 27,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · nonDerivative · entry 1 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| March 12, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | GiftOption (right to buy) · Derivative | 108,100 | $17.85 Strike: $17.85 | $1,929,585.00 |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · derivative · entry 11 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 108,100 shares Expires 2013-02-23 F3 · derivative.exercise_date: Options were granted on February 24, 2003 and are exercisable in one-third increments on February 25 of each 2004, 2005 and 2006. Read SEC document |
| March 12, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | GiftOption (right to buy) · Derivative | 108,100 | $17.85 Strike: $17.85 | $1,929,585.00 |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · derivative · entry 10 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 108,100 Underlying: Common Shares · 108,100 shares Expires 2013-02-23 F3 · derivative.exercise_date: Options were granted on February 24, 2003 and are exercisable in one-third increments on February 25 of each 2004, 2005 and 2006. F4 · ownership.nature: Reporting person transferred the reported option to his wife. Read SEC document |
| March 12, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | GiftOption (right to buy) · Derivative | 138,000 | $17.85 Strike: $17.85 | $2,463,300.00 |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · derivative · entry 9 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 138,000 shares Expires 2013-02-23 Read SEC document |
| March 12, 2003 Filed Dec 3, 2003 16:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | GiftOption (right to buy) · Derivative | 138,000 | $17.85 Strike: $17.85 | $2,463,300.00 |
DisclosureSEC source: 0000310158-03-000145 · con302.xml · derivative · entry 8 CONNORS JOSEPH C · CIK 0001023203 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 138,000 Underlying: Common Shares · 138,000 shares Expires 2013-02-23 F4 · ownership.nature: Reporting person transferred the reported option to his wife. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.